CIP321
This study will evaluate safety of advanced hybrid closed loop system

Type of Study:
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Pediatric Subjects

Study Length:
4 months

Target Age/Sex:
7 – 13 years of age, Male and Female

Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov

Staus: Enrolling

Description:

The purpose of the 321 trial is to evaluate the safety of the Advanced Hybrid Closed Loop system (AHCL) in pediatric type 1 diabetes subjects age 7 – 13 in a home setting. The main objective in conducting this research is to collect data from patients who use the AHCL system at home, at work, at school and everywhere else.

Enroll Now

Enroll Now

Address
Address
City
State/Province
Zip/Postal
If you don't have a primary care physician, just type "Do not have a primary care physician"